Verrica Pharmaceuticals Inc
VRCA
Get informed when a big investor buys or sells
+ FollowMarket Cap$97.75M
Close$
$-4.80
190.5% downside
Current Fair Value
190.5% downsideOvervalued by 190.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $97.75 Million |
|---|---|
| Enterprise Value | $89.69 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.68 |
| Beta | 1.49 |
| Outstanding Shares | 21,305,025 |
Return
| Return on Equity | -724.01% |
|---|---|
| Return on Assets | -86.58% |
| Return on Invested Capital | -205.09% |
Valuation & Multiples
| P/E Ratio | -3.27 |
|---|---|
| PEG | 0.05 |
| Price to Sales | 5.3 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.96 |
| Enterprise Value to EBIT | -3.22 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.73 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.41
Average shareholder expectationRevenue Estimate
$5.73 M
Average shareholder expectationNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-0.50
Average shareholder expectationRevenue Estimate
$6.41 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 22.43%▼ 26.35% |
|---|---|
| Total Invested | $25.28M▼ 41.43% |
| Investors Holding | 39▼ 10.00% |
ESG Score
No data
About Verrica Pharmaceuticals Inc
CEO: Ted White